Atlas Trials

Subanesthetic Esketamine in Modified ECT for Severe Depression in Adolescents: Clinical and Mechanistic Study

Clinical trial NCT07247968 · RECRUITING

Trial details

NCT number
NCT07247968
Sponsor
Min Su
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
EsketamineECTDepressionAdolescent
Start date
2025-11-25
Primary completion
2026-11-20
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.